Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT01407003 · COMPLETED
Trial details
- NCT number
- NCT01407003
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.